Successful salvage therapy of resistant gestational trophoblastic disease with etoposide, methotrexate, actinomycin-d, etoposide, cisplatin (EMA/EP)

[1]  S. Sekiya,et al.  Adjuvant Hysterectomy in Low‐Risk Gestational Trophoblastic Disease , 2001, Obstetrics and gynecology.

[2]  M. Seckl,et al.  Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  S. J. Kim,et al.  Risk factors for the prediction of treatment failure in gestational trophoblastic tumors treated with EMA/CO regimen. , 1998, Gynecologic oncology.

[4]  E S Newlands,et al.  EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  E. Lehman,et al.  Salvage surgery for chemorefractory gestational trophoblastic disease. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  A. Ayhan,et al.  Pregnancy after chemotherapy for gestational trophoblastic disease. , 1990, The Journal of reproductive medicine.

[7]  A. Altintaş,et al.  Central nervous system involvement in gestational trophoblastic neoplasia. , 2001, European journal of gynaecological oncology.